Keppra and Cholbam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Keppra (levetiracetam) and Cholbam (cholic acid). Common drug interactions include death among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Keppra and Cholbam. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

What is Cholbam?

Cholbam has active ingredients of cholic acid. eHealthMe is studying from 264 Cholbam users. Check the latest studies of Cholbam.

On Jul, 14, 2026

11 people who take Keppra and Cholbam together, and have interactions are studied.

What are the common drug interactions of Keppra and Cholbam, by gender? *:

female:

Death
Diarrhoea
Infection
Dyspnoea (difficult or laboured respiration)
Epistaxis (bleed from the nose)
Hepatomegaly (abnormal enlargement of the liver)
Hospitalisation
Interstitial lung disease
Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
Tonsillar hypertrophy (enlargement of the tonsils)

male:

Death
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Productive cough
Pyrexia (fever)
Rhinorrhoea (watery mucus discharge from the nose)
Vomiting
Hospitalisation
Renal failure (kidney dysfunction)
Venoocclusive liver disease (small veins in the liver are obstructed)
Diarrhoea

What are the common drug interactions of Keppra and Cholbam, by age (0-1 to 60+)? *:

0-1:

Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hospitalisation
Infection
Renal failure (kidney dysfunction)
Venoocclusive liver disease (small veins in the liver are obstructed)
Hepatomegaly (abnormal enlargement of the liver)
Productive cough
Pyrexia (fever)
Rhinorrhoea (watery mucus discharge from the nose)
Urinary tract infection

2-9:

Interstitial lung disease
Viral infection

10-19:

Diarrhoea
Gastric infection (infection of stomach)
Irritability
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Pain
Vomiting

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Cerebrohepatorenal Syndrome (absence of functional organelles in brain cells (by birth disorder )): 7 people, 63.64%
Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Keppra and Cholbam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously